Related references
Note: Only part of the references are listed.Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies
Habiba Kamal et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study
Mindie H. Nguyen et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission reply
Devin Razavi-Shearer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
George V. Papatheodoridis et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Reduction of acute hepatitis B through vaccination of adolescents with no decrease in chronic hepatitis B due to immigration in a low endemicity country
Jean-Luc Richard et al.
SWISS MEDICAL WEEKLY (2017)
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
Maria Buti et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Evaluation of the Compliance With Recommended Procedures in Newborns Exposed to HBsAg-Positive Mothers A Multicenter Collaborative Study
Ulrich Heininger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns
K Beckers et al.
EUROPEAN JOURNAL OF PEDIATRICS (2004)
Share Paper
